The transition from Clinical Trial Directive to Clinical Trial Regulation in Europe adds new requirements and complexities to the clinical development landscape.
The required transition of all trials concluding January 1, 2025, brings about several considerations to ensure compliance. In this webinar featuring TransPerfect Life Sciences Executive Director Pierre-Frederic Omnes, we explore topics surrounding trial transitions and answer common questions including:
- Which clinical trials need to be transitioned from the CTD to the CTR, and by when?
- What is needed to successfully transition a trial?
- What are the transparency requirements for trial transitions?